• 3 minutes Tesla is the Most American Made Car!
  • 7 minutes Should the US government be on the hook for $15 billion?
  • 9 minutes California breaks 1 GW energy storage milestone
  • 14 mins GREEN NEW DEAL = BLIZZARD OF LIES
  • 17 hours U.S. Presidential Elections Status - Electoral Votes
  • 40 mins Severe Drought in the West Will Greatly Reduce Electrical Production from Hydroelectric Turbines.
  • 2 days Сryptocurrency predictions
  • 3 hours The Climate Scare Stories Began With Far Left Ideology Per GreenPeace Co-Founder
  • 12 hours NordStream2
  • 1 day Beware the Left's 'Degrowth' Movement (i.e. why Covid-19 is Good)
Venezuela’s Oil Production Plans Are Entirely Unrealistic

Venezuela’s Oil Production Plans Are Entirely Unrealistic

Venezuela recently unveiled an ambitious…

Oil Bulls Remain Confident Despite Covid Concerns

Oil Bulls Remain Confident Despite Covid Concerns

Oil prices climbed this week…

Shell Reports $5.5 Billion Net Profit And Hikes Dividends

Shell Reports $5.5 Billion Net Profit And Hikes Dividends

Anglo-Dutch Shell reported a net…

Editorial Dept

Editorial Dept

More Info

Premium Content

Oil Prices Are On Course For Another Weekly Gain

U.S. West Texas Intermediate crude oil futures are putting in a mixed performance on Friday on low post-holiday volume. Earlier in the session, the U.S. futures contract fell more than 1% amid concerns about oversupply and doubts about a vaccine to end the coronavirus pandemic, but at the mid-session, the market is trading higher, putting it on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.

Vaccine Issues Encouraging Profit-Taking

In a slow news week, traders were once again focusing on a coronavirus vaccine, but this time, they appear to be booking profits after a big price jump as several scientists have sounded doubts over how robust the results of trials from AstraZeneca were.

Earlier in the week, both oil benchmarks jumped about 6% after AstraZeneca announced that its COVID-19 vaccine could be up to 90% effective, adding to successful trial results of Pfizer and Moderna Inc under development in the fight to end the worst pandemic in a century.

However, former pharmaceutical executives in the U.S. raised questions this week over the Oxford-AstraZeneca vaccine candidate. “We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.

US Crude Stockpiles Fall Unexpectedly, Gasoline Builds:  EIA

U.S. crude oil inventories fell last week, as well as distillate stocks, while gasoline stockpiles rose sharply, the U.S. Energy…





Leave a comment

Leave a comment




EXXON Mobil -0.35
Open57.81 Trading Vol.6.96M Previous Vol.241.7B
BUY 57.15
Sell 57.00
Oilprice - The No. 1 Source for Oil & Energy News